Participants in a celecoxib and selenium adenoma trial 1 Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention Patricia Thompson 1 , Denise J. Roe 1 , Liane Fales 1 , Julie Buckmeier 1 , Fang Wang 1 , Stanley R. Hamilton 2 , Achyut Bhattacharyya 3 , Sylvan Green 1† , Chiu-Hsieh Hsu 1 , H-H. Sherry Chow 1 , Dennis J. Ahnen 4 , C. Richard Boland 5 , Russell I. Heigh 6 , David E. Fay 7 , Maria Elena Martinez 8 , Elizabeth Jacobs 1 , Erin L. Ashbeck 1 , David S. Alberts 1 , and Peter Lance 1 Authors’ affiliations: 1 University of Arizona Cancer Center, Tucson, Arizona; 2 Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, Texas; 3 Department of Pathology, University of Arizona, Tucson, Arizona; 4 Denver Department of Veterans Affairs Medical Center and University of Colorado, Denver, Colorado; 5 GI Cancer Research Laboratory, Baylor University Medical Center, Dallas, Texas; 6 Division of Gastroenterology & Hepatology, Mayo Clinic, Scottsdale, Arizona; 7 Endoscopy Center of Western New York, Buffalo, New York; and 8 Moores UCSD Cancer Center, University of California, San Diego, La Jolla, California Deceased Running title: Participants in a celecoxib and selenium adenoma trial Keywords: colorectal adenoma, celecoxib, selenium, randomized trial Grant support: National Cancer Institute P01 CA041108 (M.P. Lance), R01 CA151708 (M.P. Lance and P. Thompson-Carino) P30 CA23074 (D.S. Alberts) Corresponding author: Peter Lance, M.D., University of Arizona Cancer Center, 1515 N. Campbell Avenue, Tucson, AZ 85724. Phone: 520-626-4492; Fax: 520-626-5348; E-mail: plance@azcc.arizona.edu Conflicts of interest: None of the authors of this manuscript has had any scientific, commercial and/or financial relationships that might be perceived as a real or potential conflict of interest. Word count: 4,704 (including 249-word Abstract and excluding Acknowledgements) Total number of figures and tables: 6 for Cancer Research. on November 26, 2021. © 2012 American Association cancerpreventionresearch.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on October 11, 2012; DOI: 10.1158/1940-6207.CAPR-12-0204